| Bosentan Spirig HC 125 mg, Filmtabletten - 56 | | 69790002 | | Spirig HealthCare AG | | Bosentan Spirig HC 125 mg, Filmtabletten | | 21.10.2025 | | | | | 21.10.2025 | | Bosentan (C02KX01) | | | | WHO-DDD | | 20.10.2030 | | | | 56 | | 02.07.10. | | | | | | | | Nein | | | | | | | | | | | | k.A. | | | | FB | | | | 7680697900024 | | Synthetika | | | | |
| | Zusammensetzung | | Filmtablette: bosentanum 125 mg ut bosentanum monohydricum 129.08 mg, cellulosum microcristallinum, carboxymethylamylum natricum A corresp. natrium max. 0.32 mg, povidonum K 30, magnesii stearas, Überzug: hypromellosum, triacetinum, talcum, E 171, E 172 (rubrum), E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Filmtabletten | | | | Wirkstoffe | Stärke | Zusätzliche Information |
|---|
| Bosentanum | 125 mg | Filmtablette |
| | | | Hilfsstoffe | Stärke | Zusätzliche Information |
|---|
| (Flavum) | | | | (Rubrum) | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Magnesii Stearas | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Talcum | | | | Triacetinum | | |
|
| | Quelle | | | |
|
|
